TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in skin issues throughout the menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cognitive Performance score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement of Lung ultrasound score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Trail Making Test (TMT) Between Baseline and End of Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Memory performance assessed using digit span memory test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: fatigue severity scale (FSS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of participants who discontinued the assigned regimen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Donor overall morbidity rate
Endpoint domain: Adverse events/effects
Primary endpoint: Recipient overall morbidity rate
Endpoint domain: Adverse events/effects
Primary endpoint: Recipient in-hospital mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Fluid responsiveness prediction capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: de Morton Mobility Index - change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in AF specific health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pressure-volume loops
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mindfulness efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lymphatic vessel visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MTD and/or RP2D of LB-LR1109
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment-Emergent Adverse Events of LB-LR1109
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Resolution of Acute Respiratory Viral Infection Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of MCG to detect myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: brain functional connectivity (FC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Myocardial re-infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence and severity of treatment-related adverse events after 1 month of therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of treatment-related adverse events after 6 months of therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Symptoms of psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in insomnia severity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Prediction of post-induction hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SLE disease activity index (SLEDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Single Assessment Numeric Evaluation (SANE)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in the American Shoulder and Elbow Surgeons Standardized Shoulder Form (ASES)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Veterans RAND 12-Item Health Survey (VR-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in the Western Ontario Osteoarthritis Shoulder Index (WOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's sleep condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's anthropometrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Children's circadian rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oxygen extraction fraction (OEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in cerebral metabolic rate of oxygen (CMRO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Kappa Opioid Receptor Occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mu Opioid Receptor Occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants Free From Aveir DR System-Related Complications at 3-months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Free From Aveir DR System-Related Complications at 12-months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With Acceptable Atrial Threshold and Amplitude Measurements at 3-months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Subjects With Acceptable Atrial Threshold and Amplitude Measurements at 12-months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With AV Synchrony Success Rate at Rest While Seated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distant metastatic disease-free rate
Endpoint domain: Mortality/survival
Primary endpoint: Signal to noise ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FACT-Cog PCI score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post-discharge antibiotic length of therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Composite of ischemic stroke or systemic embolism
Endpoint domain: Adverse events/effects
Primary endpoint: Functional Assessment of the Discussion Prioritization Tool (DPT)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: degree of renal artery stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: change of hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Self-reported adherence to fasting regimen
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of Acute Kidney Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bacterial and fungal colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in tinnitus loudness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Sonablate High-Intensity Focused Ultrasound
Endpoint domain: Adverse events/effects
Primary endpoint: Change in knee extensor and flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of acute heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes on ventilation MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postprandial muscle protein fractional synthetic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Social Relationship Coping Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Loco-regional recurrence free survival (LR-RFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Remission rate of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventral striatum (VS) activity to prediction error before tFUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ventral striatum (VS) activity to prediction error after tFUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Health Team Communication
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Symptoms related to anti-LGI1 encephalitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep microstructure - Total sleep time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stoma effluent leakage events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of dry eye symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants testing for gonorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pharmacokinetics of IkT-148009
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in CDAI at 6 Months Follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak AGRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trailing Limb Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in AUC0-2h values of Oral Glucose Tolerance Test (OGTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of 5-ALA-aided fluorescent visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuation rate after one year from insertion
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Diabetes Treatment Satisfaction Questionnaire (change, DTSQc)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ability to Respond Measured via Situational Judgement Tasks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Peak torque of plantarflexors and evertors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Star Excursion Balance Test distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of ABBV-552
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve (AUC) From Time Zero to the Last Measurable Concentration (AUCt) of ABBV-552
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression symptoms prevalence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participant Overall Satisfaction With Curriculum Content and Format
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients with abnormal physical examination findings
Endpoint domain: Adverse events/effects
Primary endpoint: Psychotic Symptom Rating Scales-Auditory Hallucination Subscale (PSYRATS-AH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stone formation data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urine oxalate (Uox) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Degree of nephrocalcinosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: H-reflex Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: M-wave Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of Post-Activation Depression (PAD) of the H-reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Acceptability of Intervention Measure (AIM) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Intervention Appropriateness Measure (IAM) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Feasibility of Intervention Measure (FIM) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood glucose response to level of food processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood insulin response to level of food processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Energy expenditure in response to level of food processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sensitivity and specificity of Endometrial Cytology and Cervical Methylation Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of ischaemic cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ECG QTc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of adequate pain relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Score of participation (< 3y)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Score of participation (3y > 15y)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: IOP measurement difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of optical diagnosis for polyps 1-5mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observational Gait Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of clinically significant FP and/or PAPP
Endpoint domain: Adverse events/effects
Primary endpoint: loss of reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Demand for the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fidelity to intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Any diagnosed psychiatric disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood vessel density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term overall mortality
Endpoint domain: Mortality/survival
Primary endpoint: Functional Mobility Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative VT burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in ADAS-Cog12 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clearance of type-specific HPV genotype(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Type, incidence and severity of adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in COPD Assessment Test (CAT) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adverse events (AEs) of YL211
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of pathogen causing cystitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Antimicrobial sensitivity concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gastric antrum diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: re-tear rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline of PTSD Symptom Scale (PSSI-5) at Posttreatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of PTSD Symptom Scale (PSSI-5) at the First Follow-Up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of PTSD Symptom Scale (PSSI-5) at the Second Follow-Up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of PTSD Symptom Scale (PSSI-5) at the Third Follow-Up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fasting Serum Bile Acid (sBA) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety Measures for Household Accidents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IgG4 in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in IL-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in IL-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in IL-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in IL-13
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in plasmablast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Beck Depression Inventory 2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Froward digit span
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Language part of Addenbrooke's Cognitive Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in Blood Total Huntingtin Protein (tHTT) at Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Redness Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change Brown Spot Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Luminosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Color Evenness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Wrinkles Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of ATRAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants in complete remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: European Organization For Research And Treatment Of Cancer Head and Neck Cancer Quality of Life Questionnaire (EORTC QLQ-H&N35)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of hospital admissions due to AECOPD
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Postoperative tissue healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin Penetration Difficulty Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Infusion Phlebitis Diagnostic Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Infiltration Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Cobb angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Accuracy of new screening modalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Volume
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: effective chest compression ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of CAR-T treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of CAR-T treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major hip injuries due to fall
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Transition Time to Full Oral Feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement (Change) in Efficiency in Oral Feed Establishment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Outcome Monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse Events Monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: TyG index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Atlanto-axial rotational mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Non-accidental early infant mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in percent plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in plaque burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alveolar cleft width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Adverse Events (AEs) Related to HTL0039732
Endpoint domain: Adverse events/effects